Qiagen (NYSE:QGEN) -27.5% after-hours as it decides to remain a stand-alone business following the conclusion of a strategic review of potential alternatives.
QGEN says it received several indications of interest for a full acquisition that were “not compelling” and thus has terminated all discussions.
Thermo Fisher (NYSE:TMO) approached the company about a potential deal, according to media reports last month.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.